State of Alaska Department of Revenue’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.2M | Buy |
18,363
+60
| +0.3% | +$45.9K | 0.15% | 108 |
|
|
2025
Q4 | $14.1M | Sell |
18,303
-950
| -5% | -$645K | 0.15% | 104 |
|
|
2025
Q3 | $10.8M | Sell |
19,253
-712
| -4% | -$403K | 0.11% | 151 |
|
|
2025
Q2 | $10.5M | Buy |
19,965
+2,640
| +15% | +$1.47M | 0.11% | 157 |
|
|
2025
Q1 | $11M | Buy |
17,325
+325
| +2% | +$224K | 0.12% | 148 |
|
|
2024
Q4 | $12.1M | Sell |
17,000
-2,294
| -12% | -$1.93M | 0.14% | 129 |
|
|
2024
Q3 | $20.3M | Sell |
19,294
-1,505
| -7% | -$1.67M | 0.22% | 77 |
|
|
2024
Q2 | $21.9M | Sell |
20,799
-440
| -2% | -$427K | 0.25% | 66 |
|
|
2024
Q1 | $20.4M | Sell |
21,239
-1,895
| -8% | -$1.8M | 0.23% | 72 |
|
|
2023
Q4 | $20.3M | Sell |
23,134
-210
| -0.9% | -$173K | 0.24% | 69 |
|
|
2023
Q3 | $19.2M | Sell |
23,344
-690
| -3% | -$542K | 0.24% | 68 |
|
|
2023
Q2 | $17.3M | Sell |
24,034
-11,780
| -33% | -$9.08M | 0.21% | 83 |
|
|
2023
Q1 | $29.4M | Sell |
35,814
-191
| -0.5% | -$144K | 0.35% | 47 |
|
|
2022
Q4 | $26M | Buy |
36,005
+4,267
| +13% | +$3.15M | 0.32% | 50 |
|
|
2022
Q3 | $21.9M | Sell |
31,738
-12,864
| -29% | -$8.1M | 0.29% | 59 |
|
|
2022
Q2 | $26.4M | Buy |
44,602
+18,137
| +69% | +$11.8M | 0.32% | 52 |
|
|
2022
Q1 | $18.5M | Buy |
26,465
+3,575
| +16% | +$2.26M | 0.19% | 98 |
|
|
2021
Q4 | $14.5M | Buy |
22,890
+4,669
| +26% | +$2.87M | 0.14% | 146 |
|
|
2021
Q3 | $11M | Buy |
18,221
+202
| +1% | +$125K | 0.11% | 207 |
|
|
2021
Q2 | $10.1M | Sell |
18,019
-9,911
| -35% | -$5.02M | 0.1% | 234 |
|
|
2021
Q1 | $13.2M | Sell |
27,930
-1,374
| -5% | -$669K | 0.14% | 164 |
|
|
2020
Q4 | $14.2M | Sell |
29,304
-1,359
| -4% | -$734K | 0.16% | 142 |
|
|
2020
Q3 | $17.2M | Sell |
30,663
-5,681
| -16% | -$3.44M | 0.21% | 96 |
|
|
2020
Q2 | $22.7M | Buy |
36,344
+22,607
| +165% | +$12.8M | 0.29% | 62 |
|
|
2020
Q1 | $6.71M | Buy |
13,737
+605
| +5% | +$250K | 0.11% | 256 |
|
|
2019
Q4 | $4.93M | Sell |
13,132
-1,090
| -8% | -$367K | 0.06% | 387 |
|
|
2019
Q3 | $3.94M | Buy |
14,222
+1,444
| +11% | +$427K | 0.05% | 419 |
|
|
2019
Q2 | $4M | Sell |
12,778
-317
| -2% | -$106K | 0.07% | 333 |
|
|
2019
Q1 | $5.38M | Sell |
13,095
-246
| -2% | -$101K | 0.1% | 242 |
|
|
2018
Q4 | $4.98M | Sell |
13,341
-73
| -0.5% | -$26.7K | 0.1% | 235 |
|
|
2018
Q3 | $5.42M | Sell |
13,414
-326
| -2% | -$124K | 0.09% | 245 |
|
|
2018
Q2 | $4.74M | Buy |
13,740
+2,650
| +24% | +$829K | 0.08% | 268 |
|
|
2018
Q1 | $3.82M | Buy |
11,090
+1,780
| +19% | +$619K | 0.08% | 296 |
|
|
2017
Q4 | $3.5M | Buy |
9,310
+8,050
| +639% | +$3.26M | 0.08% | 275 |
|
|
2017
Q3 | $563K | Buy |
+1,260
| New | +$600K | 0.03% | 667 |
|
Other funds holding REGN
VCM
N
